Barriers to Typhoid Vaccine Uptake
-
Limited disease burden & vaccine health impact data
-
Lack of consensus on vaccine choice (conjugate vs. non-conjugate)
-
No established vaccination strategies regarding who, where or how to vaccinate
-
No committed donor financing

-
Lack of focused communications and advocacy for raising country awareness, adoption & fundraising
-
Diagnostic tool limitations which hinders the ability to generate credible disease burden data (and identify high risk groups)
-
The cost-driven preference for inexpensive treatment over vaccines
-
Other potential challenges:
-
Paratyphi burden
-
Lack of WHO prequalified vaccines
-
Country political will
-
Managing typhoid as a communicable disease rather than within the immunization system
-
Current focus on Hib, pneumococcal, and rotavirus vaccine introduction in GAVI countries
Get Informed: Resources
General Information
National Ministries of Health
Meeting Presentations
-
2011 September 13 CaT Face-to-Face Meeting, Cannes
-
2011 September 14-16 VED CaT Symposium
-
2011 April 18-20 Strategic Consultation on Typhoid Vaccine Introduction and Typhoid Surveillance, Bangkok, Thailand
-
2010 Nov 8 CaT pre-SAGE meeting, Geneva
-
2010 Nov 4 ASTMH Typhoid Symposia Atlanta
-
2010 Oct 27-28 Enteric Fever Diagnostics Meeting London
-
2010 Jun 23-25 4th Global Meeting on Implementing New and Under-utilized Vaccines Workgroup 6. Vaccines of regional importance: Typhoid and Cholera
-
2009 Mar 10-11 Meeting on Typhoid Fever Vaccination in the Asia-Pacific Regions, BangKok, Thailand
-
2009 Jan 25-28 Seventh International Conference of Typhoid Fever and Other Invasive Salmonelloses
-
2005 November 12-14 Sixth International Conference on Typhoid Fever and other Salmonelloses. Research to policy-Towards more effective control of typhoid fever, Guilin, China
-
2002 February 7 The Fifth International Symposium on Typhoid Fever and other Salmonelloses, Aga Khan University (AKU), Karachi, Pakistan
Search the complete reference library here